LeWitt, Peter A.

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 7,536

AAV2-GAD gene therapy for advanced Parkinson’s disease: a double-blind, sham-surgery controlled, randomised trial

LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Thomas, K., Sarkar, A., Siddiqui, M. S., et al. (2011) · The Lancet Neurology

Deep Brain Stimulation and Movement DisordersParkinson's Disease Mechanisms and Treatments

Cited by 681

Levodopa in the treatment of Parkinson's disease: Current controversies

Olanow, C. W., Agid, Y., Mizuno, Y., Albanese, A., Bonucelli, U., Damier, P., De Yebenes, J., Gershanik, O., Guttman, M., Grandas, F., et al. (2004) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 370

Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions

Loeffler, D. A., Connor, J. R., Juneau, P. L., Snyder, B. S., Kanaley, L., DeMaggio, A. J., Nguyen, H., Brickman, C. M., & LeWitt, P. A. (1995) · Journal of Neurochemistry

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 334

A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains

Connor, J. R., Snyder, B. S., Arosio, P., Loeffler, D. A., & LeWitt, P. (1995) · Journal of Neurochemistry

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 317

The Clinical Syndrome of Striatal Dopamine Deficiency: Parkinsonism Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)

Burns, R. S., LeWitt, P. A., Ebert, M. H., Pakkenberg, H., & Kopin, I. J. (1985) · New England Journal of Medicine

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 244

Reliability of a new scale for essential tremor

Elble, R., Comella, C., Fahn, S., Hallett, M., Jankovic, J., Juncos, J. L., LeWitt, P., Lyons, K., Ondo, W., Pahwa, R., et al. (2012) · Movement Disorders

Deep Brain Stimulation and Movement DisordersMotor Control and Adaptation

Cited by 244

Clinician versus machine: Reliability and responsiveness of motor endpoints in Parkinson's disease

Heldman, D. A., Espay, A. J., LeWitt, P. A., & Giuffrida, J. P. (2014) · Parkinsonism & Related Disorders

Deep Brain Stimulation and Movement DisordersMotor Control and Adaptation

Cited by 156

Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease

Niethammer, M., Tang, C. C., LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Sarkar, A., et al. (2017) · JCI Insight

Deep Brain Stimulation and Movement DisordersParkinson's Disease Mechanisms and Treatments

Cited by 124

Prospective home-use study on non-invasive neuromodulation therapy for essential tremor

Isaacson, S. H., Peckham, E., Tse, W., Waln, O., Way, C., Petrossian, M. T., Dahodwala, N., Soileau, M. J., Lew, M., Dietiker, C., et al. (2020) · Tremor and Other Hyperkinetic Movements

Deep Brain Stimulation and Movement DisordersBotulinum Toxin and Related Neurological Disorders

Cited by 79